These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36596394)

  • 1. Remote Loading of Hydrophilic Drug into Cubosomes by Transmembrane pH-Gradient and Characterization of Drug-Loaded Cubosomes Prepared by Different Method.
    Zeng L; Ke Y; Zheng C; Song H; Liu Z; Hu X; Zhou X
    J Pharm Sci; 2023 Apr; 112(4):1119-1129. PubMed ID: 36596394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes.
    Ali MA; Kataoka N; Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
    Chem Pharm Bull (Tokyo); 2017; 65(1):42-48. PubMed ID: 28049915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
    Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
    AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
    Bhatt AB; Barnes TJ; Prestidge CA
    Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cubosomes for topical delivery of the antimicrobial peptide LL-37.
    Boge L; Hallstensson K; Ringstad L; Johansson J; Andersson T; Davoudi M; Larsson PT; Mahlapuu M; Håkansson J; Andersson M
    Eur J Pharm Biopharm; 2019 Jan; 134():60-67. PubMed ID: 30445164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cubosomes as Oral Drug Delivery Systems: A Promising Approach for Enhancing the Release of Clopidogrel Bisulphate in the Intestine.
    El-Laithy HM; Badawi A; Abdelmalak NS; El-Sayyad N
    Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1165-1173. PubMed ID: 30232306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells.
    Abdel-Bar HM; El Basset Sanad RA
    Biomed Pharmacother; 2017 Sep; 93():561-569. PubMed ID: 28686970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of particulate lipid lyotropic liquid crystalline nanocarriers using a microfluidic platform.
    Yu H; Dyett BP; Zhai J; Strachan JB; Drummond CJ; Conn CE
    J Colloid Interface Sci; 2023 Mar; 634():279-289. PubMed ID: 36542965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Delivery of Erythromycin Through Cubosomes for Acne.
    Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
    Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
    Zewail M; E Gaafar PM; Ali MM; Abbas H
    Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
    Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
    Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-bearing cubosomes prepared by liquid precursor dilution: inner ear delivery and pharmacokinetic study following intratympanic administration.
    Liu H; Wang Y; Wang Q; Li Z; Zhou Y; Zhang Y; Li S
    J Biomed Nanotechnol; 2013 Oct; 9(10):1784-93. PubMed ID: 24015508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.
    Salah S; Mahmoud AA; Kamel AO
    Drug Deliv; 2017 Nov; 24(1):846-856. PubMed ID: 28535740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma.
    Bessone CDV; Akhlaghi SP; Tártara LI; Quinteros DA; Loh W; Allemandi DA
    Eur J Pharm Sci; 2021 May; 160():105748. PubMed ID: 33567324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and physicochemical characterization of azithromycin-loaded cubosomes.
    Zaker H; Taymouri S; Mostafavi A
    Res Pharm Sci; 2023 Feb; 18(1):49-58. PubMed ID: 36846738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma.
    Umar H; Wahab HA; Ahmed N; Fujimura NA; Amjad MW; Bukhari SNA; Ahmad W
    Drug Dev Ind Pharm; 2024 Mar; ():1-14. PubMed ID: 38451066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.